Intranasal drug delivery systems offer a non-invasive approach to transporting therapeutic agents directly to the central nervous system by circumventing the blood–brain barrier. These systems exploit ...

The European Medicines Agency (EMA) on Tuesday published an analysis highlighting the complexity of developing treatments for central nervous system (CNS) disorders, such as Alzheimer's disease, ...

Summary: A milestone neuro-regenerative study has shattered a long-standing medical dogma by proving that “irreversible” damage to the connections between the human brain and spinal cord can be ...

Sanofi has tapped Alloy Therapeutics to enable development of a central nervous system drug, agreeing to pay $27.5 million in upfront and near-term fees to access an antisense platform. Alloy is ...

GLP-1 drugs may curb addiction and craving, making some patients less likely to drink alcohol. It could ease anxiety, ...

Intra-arterial drug delivery (IADD) represents a targeted therapeutic approach in which anticancer agents are administered directly into the arteries supplying central nervous system (CNS) tumours. By ...

Each part of the nervous system uses internal checks and balances to regulate its activity, responding to various factors like mood, health status, and the external environment.¹ These regulatory ...

The addictive properties of opioids and the lives shattered by their misuse and overprescription are heavily chronicled chapters of the early 21st century. For over 2 decades, scientists in academia ...

Kordata, a BIOS Ltd spinout, will advance next-generation clinical trial sites powered with neural recording technologies and ...

Researchers at the Francis Crick Institute have revealed that sensory nerve signals interfere with the immune system's ...